Open AccessLocal ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases
Author(s) -
Shuheng Shang,
Yi Su,
Zhihua Zhu,
Butuo Li,
Meiying Guo,
Yiyue Xu,
Xuejun Sun,
Linlin Wang,
Jinming Yu
Publication year - 2018
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s185592
Subject(s) - medicine , lung cancer , chemotherapy , ablative case , surgery , stage (stratigraphy) , radiation therapy , retrospective cohort study , oncology , paleontology , biology
The optimal treatment strategy for patients with non-small-cell lung cancer (NSCLC) with postoperative oligometastases is poorly defined. This two-institution analysis sought to retrospectively compare the efficacy and toxicity of local ablative treatment plus chemotherapy vs local treatment alone in patients with NSCLC who developed oligometastases after surgery.